This trial is testing a new device to help people with Alzheimer's disease. The device is used 5 days a week for 8 weeks, and people in the trial are also monitored with weekly calls from a clinical coordinator.
The BrightGo cognitive training program is being used in a clinical trial to treat patients with Alzheimer Disease. This program has been previously approved by the FDA for a different condition. All patients in this trial will be receiving the BrightGo cognitive training, there will be no placebo group.
FDA Approved Drug